These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25818503)

  • 1. Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer's Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline.
    Altamura C; Ventriglia M; Martini MG; Montesano D; Errante Y; Piscitelli F; Scrascia F; Quattrocchi C; Palazzo P; Seccia S; Vernieri F; Di Marzo V
    J Alzheimers Dis; 2015; 46(2):497-506. PubMed ID: 25818503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis.
    Caraceni P; Viola A; Piscitelli F; Giannone F; Berzigotti A; Cescon M; Domenicali M; Petrosino S; Giampalma E; Riili A; Grazi G; Golfieri R; Zoli M; Bernardi M; Di Marzo V
    Liver Int; 2010 Jul; 30(6):816-25. PubMed ID: 19840245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans.
    Fagundo AB; de la Torre R; Jiménez-Murcia S; Agüera Z; Pastor A; Casanueva FF; Granero R; Baños R; Botella C; Del Pino-Gutierrez A; Fernández-Real JM; Fernández-García JC; Frühbeck G; Gómez-Ambrosi J; Menchón JM; Moragrega I; Rodríguez R; Tárrega S; Tinahones FJ; Fernández-Aranda F
    PLoS One; 2013; 8(6):e66387. PubMed ID: 23840456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism.
    Navarini L; Bisogno T; Mozetic P; Piscitelli F; Margiotta DPE; Basta F; Afeltra A; Maccarrone M
    Int J Biochem Cell Biol; 2018 Jun; 99():161-168. PubMed ID: 29655919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoid Levels in Newborns in Relation to the Mode of Delivery.
    Jokisch V; Kroll R; Lutz B; Bindila L; Schaffelder R; Schaible T
    Am J Perinatol; 2015 Oct; 32(12):1145-50. PubMed ID: 25915139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an acute consumption of a moderate amount of ethanol on plasma endocannabinoid levels in humans.
    Feuerecker M; Hauer D; Gresset T; Lassas S; Kaufmann I; Vogeser M; Briegel J; Hornuss C; Choukèr A; Schelling G
    Alcohol Alcohol; 2012; 47(3):226-32. PubMed ID: 22278319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoid 2-arachidonoylglycerol is elevated in the coronary circulation during acute coronary syndrome.
    Jehle J; Goerich H; Bindila L; Lutz B; Nickenig G; Tiyerili V
    PLoS One; 2019; 14(12):e0227142. PubMed ID: 31887202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women.
    Pastor A; Fernández-Aranda F; Fitó M; Jiménez-Murcia S; Botella C; Fernández-Real JM; Frühbeck G; Tinahones FJ; Fagundo AB; Rodriguez J; Agüera Z; Langohr K; Casanueva FF; de la Torre R
    PLoS One; 2016; 11(2):e0148734. PubMed ID: 26849214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans.
    Thieme U; Schelling G; Hauer D; Greif R; Dame T; Laubender RP; Bernhard W; Thieme D; Campolongo P; Theiler L
    Drug Test Anal; 2014; 6(1-2):17-23. PubMed ID: 24424856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors.
    Yi B; Nichiporuk I; Nicolas M; Schneider S; Feuerecker M; Vassilieva G; Thieme D; Schelling G; Choukèr A
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jun; 67():92-7. PubMed ID: 26780604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease.
    Zelber-Sagi S; Azar S; Nemirovski A; Webb M; Halpern Z; Shibolet O; Tam J
    Obesity (Silver Spring); 2017 Jan; 25(1):94-101. PubMed ID: 27863097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of platelet activation induced by endocannabinoids in blood and plasma.
    Brantl SA; Khandoga AL; Siess W
    Platelets; 2014; 25(3):151-61. PubMed ID: 23789792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Endocannabinoids and Mortality in Hemodialysis Patients.
    Moradi H; Park C; Streja E; Argueta DA; DiPatrizio NV; You AS; Rhee CM; Vaziri ND; Kalantar-Zadeh K; Piomelli D
    Am J Nephrol; 2020; 51(2):86-95. PubMed ID: 31935741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression.
    Heyman E; Gamelin FX; Goekint M; Piscitelli F; Roelands B; Leclair E; Di Marzo V; Meeusen R
    Psychoneuroendocrinology; 2012 Jun; 37(6):844-51. PubMed ID: 22029953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.
    Côté M; Matias I; Lemieux I; Petrosino S; Alméras N; Després JP; Di Marzo V
    Int J Obes (Lond); 2007 Apr; 31(4):692-9. PubMed ID: 17224929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of endocannabinoids and endocannabinoid-like substances in human K3EDTA plasma - LC-MS/MS method validation and pre-analytical characteristics.
    Gurke R; Thomas D; Schreiber Y; Schäfer SMG; Fleck SC; Geisslinger G; Ferreirós N
    Talanta; 2019 Nov; 204():386-394. PubMed ID: 31357310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy.
    Romigi A; Bari M; Placidi F; Marciani MG; Malaponti M; Torelli F; Izzi F; Prosperetti C; Zannino S; Corte F; Chiaramonte C; Maccarrone M
    Epilepsia; 2010 May; 51(5):768-72. PubMed ID: 19817812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of dietary patterns with endocannabinoids levels in overweight and obese women.
    Yagin NL; Hajjarzadeh S; Aliasgharzadeh S; Aliasgari F; Mahdavi R
    Lipids Health Dis; 2020 Jul; 19(1):161. PubMed ID: 32631352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity.
    Quercioli A; Pataky Z; Vincenti G; Makoundou V; Di Marzo V; Montecucco F; Carballo S; Thomas A; Staub C; Steffens S; Seimbille Y; Golay A; Ratib O; Harsch E; Mach F; Schindler TH
    Eur Heart J; 2011 Jun; 32(11):1369-78. PubMed ID: 21303779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating endocannabinoids and affect regulation in human subjects.
    Coccaro EF; Hill MN; Robinson L; Lee RJ
    Psychoneuroendocrinology; 2018 Jun; 92():66-71. PubMed ID: 29627714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.